drugset / Trial / NCT00600769
Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
Phase 4
Completed
210 enrolled
The University of Texas Health Science Center at Tyler
Abbott · collab
NaSingle-groupOpen-labelTreatment
Summary
Use of oral clarithromycin for treatment of chronic lung disease due to Mycobacterium avium-intracellulare and other non-tuberculous Mycobacteria
Timeline
- Start
- 1991-01
- Primary completion
- 2006-11
- Completion
- 2017-05-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | — | Oral |